A detailed history of Atlas Legacy Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Atlas Legacy Advisors, LLC holds 1,279 shares of AMGN stock, worth $385,158. This represents 0.08% of its overall portfolio holdings.

Number of Shares
1,279
Previous 1,772 27.82%
Holding current value
$385,158
Previous $552 Million 35.31%
% of portfolio
0.08%
Previous 0.14%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 06, 2025

SELL
$262.28 - $309.85 $129,304 - $152,756
-493 Reduced 27.82%
1,279 $357 Million
Q1 2025

May 07, 2025

BUY
$258.59 - $327.36 $26,376 - $33,390
102 Added 6.11%
1,772 $552 Million
Q4 2024

Jan 31, 2025

BUY
$258.78 - $328.31 $432,162 - $548,277
1,670 New
1,670 $435 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $161B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Atlas Legacy Advisors, LLC Portfolio

Follow Atlas Legacy Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Legacy Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlas Legacy Advisors, LLC with notifications on news.